Due to the increasing life expectancy in the EU, exposure of citizens to chemicals may occur for many decades, and adverse effects may persist and evolve from childhood until old age. It is crucial to take action now and limit and manage human exposure levels to hazardous chemicals.
RISK-HUNT3R will directly relate case study compounds to exposome and biomonitoring studies through translational biomarkers, ensuring a direct translation to real-life exposure conditions. Predictions by these models will enable the understanding of acceptable exposure levels –including uncertainties– required to safeguard public health.
RISK-HUNT3R partners have strong involvement in past and present drug safety science projects, for instance from the European Innovative Medicine Initiative, and can translate findings to pharma ensuring the faster development of safer and more efficacious drugs, in particular when fast introduction of new drugs is critical for emergent situations (such as a pandemic).